TITLE

Duration of illness in Huntington's disease is not related to age at onset

AUTHOR(S)
Roos, R A; Hermans, J; Vegter-van der Vlis, M; van Ommen, G J; Bruyn, G W
PUB. DATE
January 1993
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Jan1993, Vol. 56 Issue 1, p98
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66064138

 

Related Articles

  • Octapeptide repeat insertions in the prion protein gene and early onset dementia. Croes, E. A.; Theuns, J.; Houwing-Duistermaat, J. J.; Dermaut, B.; Sleegers, K.; Roks, G.; van den Broeck, M.; van Harten, B.; van Swieten, J. C.; Cruts, M.; van Broeckhoven, C.; van Duijn, C. M. // Journal of Neurology, Neurosurgery & Psychiatry;Aug2004, Vol. 75 Issue 8, p1166 

    Objectives: The most common familial early onset dementia mutations are in the genes involved in Alzheimer's disease; the amyloid precursor protein (APP) and the presenilin 1 and 2 (PSENI and 2) genes; the prion protein gene (PRNP) may be involved. Method Following identification of a...

  • Ethical Dilemmas in Testing for Late Onset Conditions: Reactions to Testing and Perceived Impact on Other Family Members. Chapman, Elizabeth // Journal of Genetic Counseling;Oct2002, Vol. 11 Issue 5, p351 

    This paper examines some of the ethical dilemmas that arise when testing for the late onset, untreatable condition of Huntington disease (HD) specifically now that technology allows us to test younger generations of the family for the mutant gene. Drawing on interview data from families with...

  • Aging and Neurodegeneration. Donmez, Gizem // Journal of Molecular & Genetic Medicine (Library Publishing Medi;2013, Vol. 7 Issue 3, p1 

    A letter to the editor related to economic impact of aging and associated neurodegenerative diseases as Alzheimer's disease, Parkinson's disease and Huntington's disease in the U.S.

  • Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms. Pascu, Alina Mihaela; Ifteni, Petru; Teodorescu, Andreea; Burtea, Victoria; Correll, Christoph U. // International Journal of Mental Health Systems;Aug2015, Vol. 9 Issue 1, p1 

    Huntington's disease (HD) is a progressive neurodegenerative illness that affects 2–9/100.000 of the general population. The usual onset is at around age 35–40 years, but there were cases with onset above 55 years. The disease manifests clinically with many neurological and...

  • F19 Exploring the issue of swallowing in huntington's disease. Ho, A K; Drake, K; Cull, J; Barker, R A; Tabrizi, S J; Lee, P // Journal of Neurology, Neurosurgery & Psychiatry;Sep2010 Supp, Vol. 81, pA28 

    Background While swallowing function is known to be affected in the later stages of Huntington's disease, far less is known in the earlier stages of disease. Aims This study investigated swallowing and the impact of changes in swallowing issues in patients at different stages of Huntington's...

  • Clinical Characteristics of Childhood-Onset (Juvenile) Huntington Disease: Report of 12 Patients and Review of the Literature. Gonzalez-Alegre, Pedro; Afifi, Adel K. // Journal of Child Neurology;Mar2006, Vol. 21 Issue 3, p223 

    Whereas adult-onset Huntington disease is a well-characterized clinical entity, childhood-onset cases have not received as much attention. In this report, the clinical, demographic, and genetic characteristics in 12 patients with childhood-onset Huntington disease are presented and compared with...

  • Association of interleukin-10 levels with age of onset and duration of illness in patients with major depressive disorder. Gazal, Marta; Jansen, Karen; Souza, Luciano D.; Oses, Jean P.; Magalhães, Pedro V.; Pinheiro, Ricardo; Ghisleni, Gabriele; Quevedo, Luciana; Kaster, Manuella P.; Kapczinski, Flávio; da Silva, Ricardo A. // Revista Brasileira de Psiquiatria;Oct-Dec2015, Vol. 37 Issue 4, p296 

    Objective: To investigate peripheral levels of interleukin-10 (IL-10) in patients with major depressive disorder (MDD) and bipolar disorder (BD) and evaluate the relationship between IL-10, age of disease onset, and duration of illness. Methods: Case-control study nested in a population-based...

  • The role of tau in the pathological process and clinical expression of Huntington's disease. Vuono, Romina; Winder-Rhodes, Sophie; de Silva, Rohan; Cisbani, Giulia; Drouin-Ouellet, Janelle; Spillantini, Maria G.; Cicchetti, Francesca; Barker, Roger A.; REGISTRY Investigators of the European Huntington’s Disease Network // Brain: A Journal of Neurology;Jul2015, Vol. 138 Issue 7, p1907 

    Huntington's disease is a neurodegenerative disorder caused by an abnormal CAG repeat expansion within exon 1 of the huntingtin gene HTT. While several genetic modifiers, distinct from the Huntington's disease locus itself, have been identified as being linked to the clinical expression and...

  • Does sex influence age at onset in cranial-cervical and upper limb dystonia? Defcizio, G.; Abbruzzese, G.; Girlanda, P.; Vacca, L.; Currà, A.; Marchese, R.; Martino, D.; Masi, G.; Majorana, G.; Mazzella, L.; Livrea, P.; Berardelli, A. // Journal of Neurology, Neurosurgery & Psychiatry;Feb2003, Vol. 74 Issue 2, p265 

    The relation between age at dystonia onset and sex was investigated in 264 patients with cranial-cervical dystonia and 56 patients with upper limb dystonia. In cranial-cervical dystonia, women had a significantly greater age at the onset of dystonia than men. The association was independent of...

  • Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Tutuncu, Melih; Tang, Junger; Zeid, Nuhad Abou; Kale, Nilufer; Crusan, Daniel J; Atkinson, Elizabeth J; Siva, Aksel; Pittock, Sean J; Pirko, Istvan; Keegan, B Mark; Lucchinetti, Claudia F; Noseworthy, John H; Rodriguez, Moses; Weinshenker, Brian G; Kantarci, Orhun H // Multiple Sclerosis Journal;Feb2013, Vol. 19 Issue 2, p188 

    The article presents a study which investigates the onset of progressive disease course of multiple sclerosis (MS) in relation to the patient's age. The study assessed population-based and clinical-based MS cohort as well as age-of-progression-onset (t-test) and time to Expanded Disability...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics